Innovation Pharmaceuticals Inc (IPIX)

[BonelessCat]

Yesterday’s Update, point by point

1) there are now nearly 20 CDAs with several more under review.

2) there is in place bulk production for the base drug, Brilacidin, by an international manufacturer. (Keep in mind the bulk Brilacidin is then formulated into the IV, oral, rinse, salve, foam, etc)

3) IPIX is now actively pursuing dermatology Brilacidin, “including: Atopic Dermatitis, Acne, and Hidradenitis Suppurativa. All are areas of large unmet need...”

4) “the Company is in negotiations with a leading drug formulator to develop topical formulation(s) of Brilacidin for these three dermatology indications, starting in 1H2018.” (Now that almost no systemic exposure to Brilacidin has been established, a topical drug will come under a different and far less time consuming system of clinical trials.)